Dr. Reddy's Laboratories Limited (DRREDDY) — Corporate Action

· NSE 🔴 High Importance Neutral
📢 Key Event
Allotment of 6,730 equity shares under employee stock options
🔄 What Changed
Total issued share capital increased to Rs. 83,46,75,800
💡 Investor Takeaway
This issuance dilutes existing shareholders' ownership proportionally through new equity allocation.

Dr. Reddy's Laboratories allotted 6,730 fully paid equity shares of Re.1 each to eligible employees on June 19, 2026, through exercise of stock options under its 2002 and 2007 schemes, increasing total issued share capital to Rs. 83,46,75,800 and maintaining pari passu rights with existing shares.

📄 View Original Announcement (PDF)

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DRREDDY — Free

Free account · 2 AI queries/day